Fixed drug eruption and generalised erythema following etoricoxib.
Augustine
Mary
M
Sharma
Pooja
P
Stephen
John
J
Jayaseelan
Elizabeth
E
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis* / Q000201:enzymology / Q000473:pathology; D004890:Erythema / Q000139:chemically induced* / Q000201:enzymology / Q000473:pathology; D000077613:Etoricoxib; D005260:Female; D006801:Humans; D011725:Pyridines / Q000009:adverse effects*; D013450:Sulfones / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib